Clinical Takeaway
Cannabis does not affect alcohol urges the same way in everyone. People with lower working memory capacity may experience stronger alcohol cravings when using cannabis, while those with higher working memory capacity may respond differently. This finding suggests that cognitive factors should be considered when evaluating cannabis as a potential tool in alcohol use management.
#16 Working memory capacity predicts cannabis-induced effects on alcohol urge.
Citation: Gunn Rachel L et al.. Working memory capacity predicts cannabis-induced effects on alcohol urge.. Addictive behaviors. 2026. PMID: 41275744.
Design: 5 Journal: 0 N: 2 Recency: 3 Pop: 2 Human: 1 Risk: -2
This study identifies working memory capacity as a biological moderator of cannabis effects on alcohol craving, providing a mechanistic basis for the previously inconsistent clinical findings regarding cannabis and alcohol use outcomes. Understanding individual differences in cognitive capacity could enable clinicians to better predict which patients might experience reduced versus increased alcohol urge when using cannabis, improving personalized risk assessment. These findings suggest that cognitive phenotyping may help stratify patients for targeted interventions addressing co-occurring cannabis and alcohol use disorders.
Quality Gate Alerts:
- Preclinical only
Abstract: BACKGROUND: Cannabis has shown mixed results in its association with alcohol urge, which may be explained by individual differences. One such factor, working memory capacity (WMC) is associated with drug-related cue reactivity and implicated in alcohol use and problems. In the current study, we examined whether WMC moderates the acute effect of cannabis on alcohol urge in a randomized placebo-controlled crossover trial. METHODS: Participants aged 21 to 44 (N = 125, 32 % female) reporting heavy alcohol use and cannabis use ≥ twice weekly completed a laboratory protocol across three days where they smoked a placebo, 3.1 % delta-9 tetrahydrocannabinol (THC), and 7.2 % THC cannabis cigarette. Participants were asked to rate their alcohol urge pre and post smoking. Prior to the experimental sessions, participants completed WMC measures including the n-back and the complex span tasks, operation span (OS) and symmetry span (SS). RESULTS: Those with higher WMC, as assessed via the SS task, reported significantly lower alcohol urge after smoking the 7.2 %, but not the 3.1 %, THC dose, relative to placebo. Performance on the OS task was not associated with alcohol urge. Lower WMC as determined via n-back scores was associated with higher alcohol urge overall, but n-back scores did not moderate the impact of cannabis on alcohol urge. CONCLUSION: Findings suggest individuals with higher but not lower working memory experience lower alcohol urge under acute effects of cannabis. Although cannabis is increasingly perceived as a substitute for alcohol, individuals with lower working memory may be less likely to experience such benefits when attempting to reduce their drinking.
🧠 This randomized controlled trial presents an intriguing mechanistic finding that working memory capacity may predict individual variation in how cannabis affects alcohol cravings, potentially explaining why prior studies have shown mixed results in this population. The authors reasonably hypothesize that cognitive capacity influences susceptibility to drug-cue reactivity, and the crossover design strengthens causal inference compared to observational work. However, clinicians should note several important limitations: the study population appears to consist of heavy cannabis and alcohol users aged 21 to 44, which may not generalize to older adults, patients with cognitive impairment, or those using cannabis for specific medical conditions rather than recreational purposes. Additionally, acute laboratory-based alcohol urge responses may not predict real-world drinking behavior or longer-term clinical outcomes. For practitioners considering cannabis in patients with concurrent alcohol use disorder, this work suggests that neurocognitive assessment might eventually help identify which patients could benefit from cannabis as a harm-reduction strategy, but robust clinical evidence supporting this approach remains limited and such use war